Literature DB >> 9643678

Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma.

J Emmrich1, I Weber, M Nausch, G Sparmann, K Koch, M Seyfarth, M Löhr, S Liebe.   

Abstract

BACKGROUND/AIMS: Chronic pancreatitis is histologically characterized by an extended fibrosis and infiltration of leukocytes. We intended to differentiate the infiltration to evaluate the inflammatory process.
METHODS: Samples of tissues of normal pancreas (NP, n = 12), of chronic pancreatitis (CP, n = 7), and pancreatic tissues surrounding pancreatic carcinoma (CA, n = 7) were investigated by immunohistochemical staining using the APAAP technique.
RESULTS: In normal pancreas, mononuclear cells (47.1 +/- 26.0 cells/mm2) were observed with a predominance of macrophages (56.3%) and T lymphocytes (31.3%) which were differentiated in CD8+ lymphocytes (9.3 +/- 7.2 cells/ mm2) and CD4+ lymphocytes (6.7 +/- 3.2 cells/mm2). Rarely, plasma cells (5.3%) and B lymphocytes (7.1%) could be detected. In pancreatic tissue of patients with CP and in CA there was a significant increase of mononuclear cells to 264.4 +/- 120.3 cells/mm2 and 284.3 +/- 67.8 cells/mm2, respectively. In both diseases percentages of T lymphocytes (CP: 50.5%; CA: 48.1%) were higher than in normal controls. CD4+/CD8+ ratio of 0.77 in CP and 0.82 in CA demonstrated a predominance of CD8+ cells compared to the peripheral blood. In NP and CA, nearly all T lymphocytes expressed CD45R0 identifying memory cells, while only 58% of T lymphocytes were CD45R0 positive in CP.
CONCLUSION: Our data suggest that the investigated cases of CP were of a common inflammatory type rather than due to an autoimmunological reaction. CD8+ T lymphocytes were the predominant T cell subset in the inflammatory infiltrates in both CP and CA.

Entities:  

Mesh:

Year:  1998        PMID: 9643678     DOI: 10.1159/000007488

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  41 in total

1.  The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis.

Authors:  J Köninger; N A Giese; M Bartel; F F di Mola; P O Berberat; P di Sebastiano; T Giese; M W Büchler; H Friess
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

2.  A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis.

Authors:  T Reding; D Bimmler; A Perren; L-K Sun; F Fortunato; F Storni; R Graf
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

Review 3.  Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.

Authors:  Lei Zheng; Jing Xue; Elizabeth M Jaffee; Aida Habtezion
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

Review 4.  CAR T-cell therapy for pancreatic cancer.

Authors:  Carl J DeSelm; Zachary E Tano; Anna M Varghese; Prasad S Adusumilli
Journal:  J Surg Oncol       Date:  2017-03-27       Impact factor: 3.454

5.  An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis.

Authors:  Maisam Abu-El-Haija; Marek Sinkora; David K Meyerholz; Michael J Welsh; Paul B McCray; John Butler; Aliye Uc
Journal:  Pancreatology       Date:  2011-11-01       Impact factor: 3.996

6.  Cytokine gene expression in peripheral blood mononuclear cells reflects a systemic immune response in alcoholic chronic pancreatitis.

Authors:  C Hanck; S Rossol; A Hartmann; M V Singer
Journal:  Int J Pancreatol       Date:  1999-12

7.  Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Biomedical Imaging and Bioengineering Workshop.

Authors:  Kimberly A Kelly; Michael A Hollingsworth; Randall E Brand; Christina H Liu; Vikesh K Singh; Sudhir Srivastava; Ajay D Wasan; Dhiraj Yadav; Dana K Andersen
Journal:  Pancreas       Date:  2015-11       Impact factor: 3.327

8.  Enhanced expression of interleukin-18 in serum and pancreas of patients with chronic pancreatitis.

Authors:  Alexander Schneider; Stephan-L Haas; Ralf Hildenbrand; Sören Siegmund; Iris Reinhard; Helmut Nakovics; Manfred-V Singer; Peter Feick
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

Review 9.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

Review 10.  [Duodenum-preserving pancreas head resection-an operative technique for retaining the organ in the treatment of chronic pancreatitis].

Authors:  J Köninger; H Friess; M Müller; M Wirtz; M Martignioni; M W Büchler
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.